New study aims to slow memory decline with caregiver support
NCT ID NCT06408103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 12-week program for people with mild cognitive impairment (early memory loss) and their main family caregiver. The program includes professional-led sessions and caregiver support to improve thinking, memory, and quality of life for both. Researchers will track changes in cognitive function, independence, and caregiver burden over 9 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 102 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2024
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion and exclusion criteria for elderly adults Inclusion criteria 1. Age of 55 years or older. 2. Diagnosis of mild cognitive impairment by a Psychiatrist/Neurologist supported by neuropsychological evaluation. 3. Functionality for instrumental activities. 4. Basic proficiency in reading and writing. 5. Absence of untreated hearing impairment and/or uncorrected visual problems. 6. Availability of a primary family caregiver (to be identified). 7. IPAQ with low level of physical activity (pending cutoff point), PARQ and you Fit (pending review). 8. Barthel Index equal to or greater than 80 points. 9. Functional capacity for short-distance ambulation without permanent use of mechanical aids such as wheelchairs. 10. Individuals with a BMI greater than 18.5. 11. Gastrointestinal tract without surgical resections. 12. Tolerance to oral feeding. 13. Vaccination against COVID-19. Exclusion criteria 1. History of psychosis or congenital intellectual disability. 2. Presence of a central nervous system pathology that could affect cognition (Parkinson's disease, tumors, encephalitis, epilepsy, cerebrovascular disease, traumatic brain injury). 3. Presence of untreated psychiatric disorders, anxiety, depression (Yesavage). 4. Presence of clinically significant systemic diseases (thyroid dysfunction, vitamin B12 deficiency, insulin-dependent diabetes, syphilis, HIV infection, Epstein Barr infection, advanced stage renal failure, cirrhosis). Evaluated through medical history and self-report. 5. Older adult with Chronic Kidney Disease, Hepatopathies (hepatitis, liver cirrhosis), 6. Pulmonary Diseases, or requiring oxygen support, Crohn's Disease, and Colitis. 7. Individual with oncological pathology who has received or is receiving chemotherapy. 8. Individual who has received probiotics or prebiotics in the last 30 days. 9. Presence of clinically significant, active infectious etiology diarrhea. 10. Current or prior abuse of alcohol, tobacco, or drugs. 11. Use of steroids or immunosuppressants in the last 30 days. 12. Recent use of antibiotics, antifungals, or antivirals (excluding topicals) in the last 3 months. 13. Individual who voluntarily decides to withdraw from the study. 14. Older adult without oral, enteral, or parenteral nutritional support. 15. Poor tolerance to exercise, vertigo, medical exercise restriction. Elimination criteria 1. Institutionalized or hospitalized for more than 1 week, or death during the intervention phase (review and clarity on death). 2. Failure to attend more than 34% of sessions with professional accompaniment (applies to the dyad). Inclusion and exclusion criteria for caregivers ( Family members) Inclusion criteria 1. Adults aged 18 years or older. 2. Basic proficiency in reading and writing. 3. Having a level of kinship (consanguineous or non-consanguineous). 4. Vaccination against COVID-19.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mild cognitive impairment are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Universidad de Santander / Universidad Manuela Beltrán /FOSCAL
RECRUITINGBucaramanga, Santander Department, 62215, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized home program slow memory decline?
- Walking memory tests may reveal early Parkinson's clues
- Can tango rewire the brain? dance program tested for Parkinson's and dementia
- Can tiny bursts of baduanjin exercise sharpen a fading memory?
- Can pool workouts plus brain games sharpen memory in aging veterans?
- Can home exercise keep older adults with cognitive frailty on their feet?